- Home
- ACIU vs ATHR Comparison
ACIU vs ATHR Comparison
Compare ACIU & ATHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- ATHR
- Stock Information
- Founded
- ACIU 2003
- ATHR 2003
- Country
- ACIU Switzerland
- ATHR United States
- Employees
- ACIU N/A
- ATHR N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- ATHR
- Sector
- ACIU Health Care
- ATHR
- Exchange
- ACIU Nasdaq
- ATHR NYSE
- Market Cap
- ACIU 168.7M
- ATHR 182.7M
- IPO Year
- ACIU 2016
- ATHR 2025
- Fundamental
- Price
- ACIU $2.07
- ATHR $14.00
- Analyst Decision
- ACIU Strong Buy
- ATHR
- Analyst Count
- ACIU 1
- ATHR 0
- Target Price
- ACIU $12.00
- ATHR N/A
- AVG Volume (30 Days)
- ACIU 119.1K
- ATHR 39.6K
- Earning Date
- ACIU 08-05-2025
- ATHR 05-16-2025
- Dividend Yield
- ACIU N/A
- ATHR N/A
- EPS Growth
- ACIU N/A
- ATHR N/A
- EPS
- ACIU N/A
- ATHR N/A
- Revenue
- ACIU $32,014,254.00
- ATHR $1,406,012.00
- Revenue This Year
- ACIU N/A
- ATHR N/A
- Revenue Next Year
- ACIU $533.21
- ATHR N/A
- P/E Ratio
- ACIU N/A
- ATHR N/A
- Revenue Growth
- ACIU 91.20
- ATHR N/A
- 52 Week Low
- ACIU $1.43
- ATHR $4.63
- 52 Week High
- ACIU $4.37
- ATHR $19.69
- Technical
- Relative Strength Index (RSI)
- ACIU 59.88
- ATHR N/A
- Support Level
- ACIU $1.79
- ATHR N/A
- Resistance Level
- ACIU $2.10
- ATHR N/A
- Average True Range (ATR)
- ACIU 0.17
- ATHR 0.00
- MACD
- ACIU 0.00
- ATHR 0.00
- Stochastic Oscillator
- ACIU 71.93
- ATHR 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ATHR AETHER HOLDINGS INC
Aether Holdings Inc is an emerging financial technology platform company that offers proprietary research analytics, data and tools for both institutional and retail equity traders through flagship platform, SentimenTrader.com. Its platform currently provides coverage of U.S. equity and option securities, evaluating the equities and options markets and conducting assessments through analysts and technology daily.